PanCAN President and CEO Julie Fleshman, JD, MBA, moderates this event featuring a panel of pancreatic cancer research and treatment experts discussing:
Join us as we:
- Innovations in pancreatic cancer research and how PanCAN's strategy tackling the disease from both ends of the spectrum – early detection to more effective treatments – is working
- The latest updates on the PanCAN Precision PromiseSM clinical trial platform and the PanCAN Early Detection Initiative, and how they can help patients of today and tomorrow
- A donor’s perspective on why they give to PanCAN to support research, and learn how every donation improves patients' lives
RECORDING COMING SOON
Julie M. Fleshman, JD, MBA
PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes
Lynn Matrisian, PhD, MBA
PanCAN Chief Science Officer, leading research and clinical initiatives, including the PanCAN Early Detection Initiative, PanCAN’s Research Grants Program and more
Vincent Picozzi, MD
Oncologist, Virginia Mason Medical Center, Division of Hematology/Oncology; Director, Pancreas Center of Excellence; PanCAN Precision Promise Clinical Trial Consortium Chair and Steering Committee member; member, PanCAN Scientific & Medical Advisory Board
Suresh T. Chari, MD
Professor, Department of Gastroenterology Hepatology and Nutrition, Division of Internal Medicine, MD Anderson Cancer Center; PanCAN Early Detection Initiative Principal Investigator; member, PanCAN Scientific & Medical Advisory Board
Linda E. Amuso
Senior Partner, Human Capital Solutions for Aon, based in San Francisco; former caregiver for her wife, whom she lost to pancreatic cancer in 2016; proud supporter of PanCAN research and clinical initiatives
RSVP NOWThe Impact of Your Gifts: How You’re Advancing Pancreatic Cancer Research
Join us for a webinar on Thursday, May 26, featuring the latest updates on the research front, as well as how you are advancing progress and innovation.
We're looking forward to sharing with you the latest updates in pancreatic cancer research. Add this event to your calendar and save pancan.org/research2022 for webinar day, Thursday, May 26, 11 a.m. PT / 2 p.m. ET. Add to Calendar
(If you're prompted to download an iCalendar file, save it to your device and open it)
Enter the email address you used to RSVP for the event.
DIDN'T RSVP? Sign up now and get immediate access to the event.
1500 Rosecrans Avenue, Suite 200
Manhattan Beach, CA 90266 - Map
Phone: (310) 725-0025
Toll Free: (877) 573-9971
Fax: (310) 725-0029
Get Our Latest News!
Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.
The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.